Abiopharma

🔍 Aspe Bernal Monica (Director)

Company: Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (VLRS)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 106,461 shares of Series A shares of common stock (Direct)
  Date: 2026-04-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 196,414.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 56,811 shares of Restricted Securities Units (BoDIP) (Derivative)
  Date: 2026-04-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 56,811.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 106,461 shares of Restricted Securities Units (BoDIP) (Derivative)
  Date: 2026-04-28 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F1, F1

Footnotes:

• F1: The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date.
• F2: Each RSU represents a contingent right to receive on Series A share of common stock.
• F3: The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.